Atherosclerosis
Prediabetes: Impact on cardiovascular risk and emerging therapeutic strategies

ReviewInterventions
- Behavioural
- GLP-1 receptor agonists
- GLP-1 and incretin signalling
- Prediabetes
- Cardiovascular disease
- Humans
The paper
University of Pisa
Atherosclerosis, 3 Sep 2026
doi.org/10.1016/j.atherosclerosis.2026.121898PubMed 42696840
